Jun An Kang Group Inc. (IHGP)
OTCMKTS · Delayed Price · Currency is USD
0.0011
+0.0005 (83.33%)
At close: May 14, 2026
Jun An Kang Group Revenue
In the year 2007, Jun An Kang Group had annual revenue of $4.47M with 39.85% growth. Jun An Kang Group had revenue of $1.10M in the quarter ending December 31, 2007, with 6.39% growth.
Revenue
4.47M
Revenue Growth
+39.85%
P/S Ratio
0.42
Revenue / Employee
186.40K
Employees
24
Market Cap
1.89M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2007 | 4.47M | 1.27M | 39.85% |
| Dec 31, 2006 | 3.20M | 1.01M | 45.82% |
| Dec 31, 2005 | 2.19M | -4.40M | -66.71% |
| Dec 31, 2004 | 6.59M | -329.91K | -4.77% |
| Dec 31, 2003 | 6.92M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Veradigm | 594.41M |
| Glass House Brands | 177.68M |
| Elite Pharmaceuticals | 140.12M |
| Panacea Life Sciences Holdings | 2.76M |
| InVitro International | 811.29K |
| Gold Enterprise Group | 559.55K |
| Iterum Therapeutics | 390.00K |
| Premier Biomedical | 14.28K |